Appraising Evidence into our Practice. Objectives Deciding the research result into practice in specific context Interpreting/calculating Number Needed.

Slides:



Advertisements
Similar presentations
Title of the journal club (Paper & authors; presenters)
Advertisements

Basic statistics.
How to assess an abstract
Reporting drugs and treatments Thomas Abraham JMSC 6090.
Assessment of Harm based on our best available evidences The EBM workshop A.A.Haghdoost, MD; PhD of Epidemiology
Comparing Two Proportions (p1 vs. p2)
Reporting drugs and treatments Thomas Abraham. What we will learn today The difference between absolute and relative risk reduction A basic way to interpret.
Step 3: Critically Appraising the Evidence: Statistics for Harm and Etiology.
Understanding real research 3. Assessment of risk.
Measures of Effect: An Introduction Epidemiology Supercourse Astana, July 2012 Philip la Fleur, RPh MSc(Epidem) Deputy Director, Center for Life Sciences.
Introduction to Critical Appraisal : Quantitative Research
CRITICAL APPRAISAL Dr. Cristina Ana Stoian Resident Journal Club
Critical Appraisal of an Article on Therapy. Why critical appraisal? Why therapy?
ABCWINRisk and Statistics1 Risk and Statistics Risk Assessment in Clinical Decision Making Ulrich Mansmann Medical Statistics Branch University of Heidelberg.
Clinical trial The Way We Make Progress Against Disease Prof. Ashry Gad Mohamed Prof. of Epidemiology College of Medicine & KKUH.
Statistics for Health Care
TREATMENT 1 Evaluation of interventions How best assess treatments /other interventions? RCT (randomised controlled trial)
Critical Appraisal of an Article on Therapy (2). Formulate Clinical Question Patient/ population Intervention Comparison Outcome (s) Women with IBS Alosetron.
Understanding study designs through examples Manish Chaudhary MPH (BPKIHS)
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
EBD for Dental Staff Seminar 2: Core Critical Appraisal Dominic Hurst evidenced.qm.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 14 Screening and Prevention of Illnesses and Injuries: Research Methods.
DEB BYNUM, MD AUGUST 2010 Evidence Based Medicine: Review of the basics.
CAT 2: Therapy Maribeth Chitkara, MD Rachel Boykan, MD Stony Brook Long Island Children’s Hospital.
Measures of Association
Risk Concepts and Glossary. Cross-sectional study The observation of a defined population at a single point in time or time interval. Exposure and outcome.
Analyzing Randomized Control Trial: ITT vs. PP vs. AT Proceedings from Journal club….. Vikash.
How to Analyze Therapy in the Medical Literature (part 2)
Tissue Plasminogen Activator for Acute Ischemic Stroke National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
CAT 3 Harm, Causation Maribeth Chitkara, MD Rachel Boykan, MD.
Understanding real research 4. Randomised controlled trials.
Measures of Association Professor Mobeen Iqbal Shifa College of Medicine.
November 5, 2014 Matthew Tuck, MD Hospitalist, Veterans Affairs Medical Center Assistant Professor of Medicine, George Washington University.
Literature Appraisal Effectiveness of Therapy. Measures of treatment effect Statistical significance Odds ratio Relative risk Absolute risk reduction.
Stats Facts Mark Halloran. Diagnostic Stats Disease present Disease absent TOTALS Test positive aba+b Test negative cdc+d TOTALSa+cb+da+b+c+d.
Evidence and Experience Based Medicine Successfully implementing research into your practice.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
A Simple Method for Evaluating the Clinical Literature “PP-ICONS” approach Based on Robert J. Flaherty - Family Practice Management – 5/2004.
Risks & Odds Professor Kate O’Donnell. When talking about the chance of something happening, e.g. death, hip fracture, we can talk about: risk and relative.
Compliance Original Study Design Randomised Surgical care Medical care.
Vanderbilt Sports Medicine Evidence-Base Medicine How to Practice and Teach EBM Chapter 5 : Therapy.
/ 161 Saudi Diploma in Family Medicine Center of Post Graduate Studies in Family Medicine EBM Therapy Articles Dr. Zekeriya Aktürk
Course: Research in Biomedicine and Health III Seminar 4: Critical assessment of evidence.
EBM --- Journal Reading Presenter :林禹君 Date : 2005/10/26.
From EBM to SDM: Michel Labrecque MD PhD Michel Cauchon MD Department of Family and Emergency Medicine Université Laval Teaching how to apply evidence.
CRITICAL APPARAISAL OF A PAPER ON THERAPY 421 CORSE EVIDENCE BASED MEDICINE (EBM)
Critical appraisals: Treatment. CLINICAL TRIAL = a prospective study comparing the effect and value of intervention(s) against a control in human beings.
Article Title Resident Name, MD SVCH6/13/2016 Journal Club.
Critical Appraisal of a Paper Feedback. Critical Appraisal Full Reference –Authors (Surname & Abbreviations) –Year of publication –Full Title –Journal.
Risk Different ways of assessing it. Objectives Be able to define and calculate: Absolute risk (reduction) Relative risk (reduction) Number needed to.
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
Critical Appraisal II Prepared by Dr. Hoda Abd El Azim.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
GP ST2 Group, 28/9/11 Tom Gamble
EBM R1張舜凱.
HelpDesk Answers Synthesizing the Evidence
Speaker :R1吳師豪 Supervisor:VS吳孟書
EVIDENCE BASED MEDICINE
Polypharmacy In Adults: Small Test of Change
Dabigatran vs Warfarin in Patients with Atrial Fibrillation – Results
remember to round it to whole numbers
Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197
Interpreting Basic Statistics
The Research Question Background: Question:
EBM – therapy Dr. Tina Dewi J , dr., SpOG
What Really is Evidence Based Medicine?
Evidence Based Medicine 2019 A.Bornstein MD FACC Assistant Professor of Medicine Hofstra Northwell School of Medicine Hempstead, Long Island.
Basic statistics.
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

Appraising Evidence into our Practice

Objectives Deciding the research result into practice in specific context Interpreting/calculating Number Needed to Treat (NTT) Interpreting pre and post test Interpreting/calculating Number Needed to Harm (NHH)

Introduction Health related research takes places over the world Specific situation or patient where the study was taking place probably different with the current situation Sample population characteristic ? Standard of services ?

Assessing Applicability Are the Findings Applicable in My setting? What do The result Mean for my Patient? Is the quality of the Study good enough to use the result?

Factors to consider when assessing applicability Characteristic of the participant: co morbidity, severity, gender Characteristic of the participant: co morbidity, severity, gender Feasibility to introduce the intervention: specialist unit, generalist unit, management system? Feasibility to introduce the intervention: specialist unit, generalist unit, management system? Think about cost and benefit Think about cost and benefit Patients preference. Forcing patient to accept the intervention is unethical. Patients preference. Forcing patient to accept the intervention is unethical.

Meaning the Result Study Quality of the study design is the most important thing Quality of the study design is the most important thing Avoiding the result by chance Avoiding the result by chance ℘ < (probability by chance < 1 in 1000) ℘ < (probability by chance < 1 in 1000) Number needed to treat (NNT) is useful for interpreting the effectiveness Number needed to treat (NNT) is useful for interpreting the effectiveness

Example Patient: Sandra, 11 y.o with 4 admission within 6 month EBP Question: Does a structured nurse-lead discharge package result reduce level of readmission in children with acute asthma? Evidence: Wisendly, C (1999) Stucture discharge procedure for childern with acute asthma: an RCT study. Journal of children nursing 4 (40):77

Example Result Report: Reduction in admission at 6 month. Control group: 30 of 80 Intervention group: 12 of 80 Make 2 x 2 Table

Outcome: Readmission within 6 month Total Group Study PresentAbsent Intervention 12 ab 68a + b = 80 Control30 c d 50c + d = 80 Total 42 (a + c) (b + d) 118a + b+ c + d = 160

Calculating NNT StepMeasureFormulaExample 1234 Experiment even rate (EER) Control even rate (CER) Absolute risk reducation (ARR) NNT a/a + b c/c + d CER – EER 100/AAR 12/ = 15% 30/ = 37% 37-15=22% 100/22 = 5 (rounded up)

The Mean NNT = 5 means, 5 children need to received structured discharge package to prevent one extra child from being readmitted if they had received standard care.

Number Needed to Harm Patient: florence, 33, using oral contraception, smoke cigarettes/day. Clinical question: are women who smoke with oral contraception at higher risk of myocardial infarction comparing with non smoker? Evidence: Matt, J (1999)Risk of myocardial infarction and angina in users of oral contraception. Update analysis of Cohort study. British journal of obstetric 3(90)pp1-5

Number Needed to Harm Result: In heavy smokers there is a fourfold in the risk of myocardial infarction if the pill of oral contraception is taken. 0,24 per 1000 women/year in heavy smoker who never used oral contraception to 1,18 per 1000 women at risk in current users of oral contraception. Heavy smoker relative risk is 4.0 for ex user of oral contraceptive pill, 4.2 for ever-user and 4.9 for current user

Calculating NNH Adverse Outcome: Myocardial infacrtion Total Group Study PresentAbsent Yes: heavy smoker + oral cont aba / (a+ b) = rate in yes group No: Non smoker + No oral cont c dc / (c + d = Rate in no grup

Calculation MeasureFormulaExample Relative risk (RR) Absolute risk increase (ARI) Number needed to harm (NNH) a/(a+b)c/(c+d)a/(a+b)-c/(c+d)1/ARI 1.18/0.24 = =0.94 per 1000 person 1/ =1063

The Mean The number of women who smoke heavily that would have to take oral contraception for 1 year to cause one extra myocardial infarction. In this study, a total 1063 heavy smoker would need to take oral contraception for 1 year for 1 extra women to experience a myocardial infarction.

Conclusion Are the Findings Applicable in My setting? What do The result Mean for my Patient? Is the quality of the Study good enough to use the result?

Conclusion We know the patient We can compare the evidence with the local situation Cost and benefit should be consider However, there are no perfect study as every design has they own limitation

Developing Guideline

Level of Evidence & Recomendation